Avadel Pharmaceuticals Reports First Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Avadel Pharma (AVDL) Reports Q1 EPS of $0.26, Offers Guidance
May 9, 2017 7:39 AM EDTAvadel Pharma (NASDAQ: AVDL) reported Q1 EPS of $0.26, versus $0.04 reported last year. Revenue for the quarter came in at $52.5 million, versus $36.2 million reported last year.
2017 Guidance
The Company is increasing its full year adjusted EPS guidance to a range of $0.30 to $0.45 per... More



